152 related articles for article (PubMed ID: 25351211)
21. HOXC9 links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma.
Mao L; Ding J; Zha Y; Yang L; McCarthy BA; King W; Cui H; Ding HF
Cancer Res; 2011 Jun; 71(12):4314-24. PubMed ID: 21507931
[TBL] [Abstract][Full Text] [Related]
22. Neuronal cell differentiation of human neuroblastoma cells by retinoic acid plus herbimycin A.
Preis PN; Saya H; Nádasdi L; Hochhaus G; Levin V; Sadée W
Cancer Res; 1988 Nov; 48(22):6530-4. PubMed ID: 2846152
[TBL] [Abstract][Full Text] [Related]
23. Β-carotene inhibits neuroblastoma tumorigenesis by regulating cell differentiation and cancer cell stemness.
Lim JY; Kim YS; Kim KM; Min SJ; Kim Y
Biochem Biophys Res Commun; 2014 Aug; 450(4):1475-80. PubMed ID: 25019987
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 is a direct transcriptional target of GATA3 in neuroblastoma tumor cells.
Molenaar JJ; Ebus ME; Koster J; Santo E; Geerts D; Versteeg R; Caron HN
Oncogene; 2010 May; 29(18):2739-45. PubMed ID: 20154722
[TBL] [Abstract][Full Text] [Related]
25. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions.
Peverali FA; Orioli D; Tonon L; Ciana P; Bunone G; Negri M; Della-Valle G
Oncogene; 1996 Jan; 12(2):457-62. PubMed ID: 8570225
[TBL] [Abstract][Full Text] [Related]
26. A proline-rich loop mediates specific functions of human sialidase NEU4 in SK-N-BE neuronal differentiation.
Bigi A; Tringali C; Forcella M; Mozzi A; Venerando B; Monti E; Fusi P
Glycobiology; 2013 Dec; 23(12):1499-509. PubMed ID: 24030392
[TBL] [Abstract][Full Text] [Related]
27. Influence of LOX/COX inhibitors on cell differentiation induced by all-trans retinoic acid in neuroblastoma cell lines.
Redova M; Chlapek P; Loja T; Zitterbart K; Hermanova M; Sterba J; Veselska R
Int J Mol Med; 2010 Feb; 25(2):271-80. PubMed ID: 20043138
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide negatively regulates proliferation and promotes neuronal differentiation through N-Myc downregulation.
Ciani E; Severi S; Contestabile A; Bartesaghi R; Contestabile A
J Cell Sci; 2004 Sep; 117(Pt 20):4727-37. PubMed ID: 15331636
[TBL] [Abstract][Full Text] [Related]
29. SOX2 promotes tumorigenicity and inhibits the differentiation of I-type neuroblastoma cells.
Yang S; Zheng J; Xiao X; Xu T; Tang W; Zhu H; Yang L; Zheng S; Dong K; Zhou G; Wang Y
Int J Oncol; 2015 Jan; 46(1):317-23. PubMed ID: 25333857
[TBL] [Abstract][Full Text] [Related]
30. GATA3 is a reliable marker for neuroblastoma in limited samples, including FNA Cell Blocks, core biopsies, and touch imprints.
Wiles AB; Karrs JX; Pitt S; Almenara J; Powers CN; Smith SC
Cancer Cytopathol; 2017 Dec; 125(12):940-946. PubMed ID: 28976719
[TBL] [Abstract][Full Text] [Related]
31. Specificity protein 1 regulates topoisomerase IIβ expression in SH-SY5Y cells during neuronal differentiation.
Guo H; Cao C; Chi X; Zhao J; Liu X; Zhou N; Han S; Yan Y; Wang Y; Xu Y; Yan Y; Cui H; Sun H
J Neurosci Res; 2014 Oct; 92(10):1374-83. PubMed ID: 24801450
[TBL] [Abstract][Full Text] [Related]
32. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
[TBL] [Abstract][Full Text] [Related]
33. Restoration of functional PAX3 transcriptional factor enhanced neuronal differentiation in PAX3b isoform-depleted neuroblastoma cells.
Muralidharan N; Murugan A; Raj PA; Jothi M
Cell Tissue Res; 2023 Jan; 391(1):55-65. PubMed ID: 36378335
[TBL] [Abstract][Full Text] [Related]
34. EPAS1/HIF2α correlates with features of low-risk neuroblastoma and with adrenal chromaffin cell differentiation during sympathoadrenal development.
Westerlund I; Shi Y; Holmberg J
Biochem Biophys Res Commun; 2019 Jan; 508(4):1233-1239. PubMed ID: 30563765
[TBL] [Abstract][Full Text] [Related]
35. Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression.
Westerlund I; Shi Y; Toskas K; Fell SM; Li S; Surova O; Södersten E; Kogner P; Nyman U; Schlisio S; Holmberg J
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6137-E6146. PubMed ID: 28696319
[TBL] [Abstract][Full Text] [Related]
36. Cytokines inhibit norepinephrine transporter expression by decreasing Hand2.
Pellegrino MJ; Parrish DC; Zigmond RE; Habecker BA
Mol Cell Neurosci; 2011 Mar; 46(3):671-80. PubMed ID: 21241805
[TBL] [Abstract][Full Text] [Related]
37. Optimising the chick chorioallantoic membrane xenograft model of neuroblastoma for drug delivery.
Swadi R; Mather G; Pizer BL; Losty PD; See V; Moss D
BMC Cancer; 2018 Jan; 18(1):28. PubMed ID: 29301505
[TBL] [Abstract][Full Text] [Related]
38. The metallophosphodiesterase Mpped2 impairs tumorigenesis in neuroblastoma.
Liguori L; Andolfo I; de Antonellis P; Aglio V; di Dato V; Marino N; Orlotti NI; De Martino D; Capasso M; Petrosino G; Schramm A; Navas L; Tonini GP; Eggert A; Iolascon A; Zollo M
Cell Cycle; 2012 Feb; 11(3):569-81. PubMed ID: 22262177
[TBL] [Abstract][Full Text] [Related]
39. 11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma.
Siaw JT; Javanmardi N; Van den Eynden J; Lind DE; Fransson S; Martinez-Monleon A; Djos A; Sjöberg RM; Östensson M; Carén H; Trøen G; Beiske K; Berbegall AP; Noguera R; Lai WY; Kogner P; Palmer RH; Hallberg B; Martinsson T
Cell Rep; 2020 Sep; 32(12):108171. PubMed ID: 32966799
[TBL] [Abstract][Full Text] [Related]
40. Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma.
Marayati R; Williams AP; Bownes LV; Quinn CH; Stewart JE; Mroczek-Musulman E; Atigadda VR; Beierle EA
J Pediatr Surg; 2020 Jun; 55(6):1072-1080. PubMed ID: 32164984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
